SCHEMBL1662575

SCHEMBL1662575

Cc1nc(N)c[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10696855 0.97 — —
SCHEMBL65108 0.71 — —
Hydrochloric Acid SCHEMBL7285171 0.69 — —
SCHEMBL8324752 0.67 KDM4E (0.38) —
SCHEMBL3403486 0.67 — —
SCHEMBL1199229 0.67 — —
SCHEMBL19577698 0.67 — —
SCHEMBL12777891 0.67 — —
SCHEMBL102334 0.67 — —
SCHEMBL3272627 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114976047-B Catalyst for electro-oxidation of methanol and preparation method thereof 南京大学 2024-08-23 — — CN claimed
CN-114976047-A Catalyst for methanol electrooxidation and preparation method thereof 南京大学 2022-08-30 — — CN claimed
CN-105492904-A Separating agent NAT UNIV CORP KYOTO INST OF TECH 2016-04-13 — — CN claimed
US-20250084074-A1 SUBSTITUTED HETEROCYCLES AS HSET INHIBITORS MERCK PATENT GMBH (DE) 2025-03-13 — — US disclosed
CN-119421877-A Substituted heterocyclic compounds as HSET inhibitors 默克专利股份公司 2025-02-11 — — CN disclosed
EP-4463444-A1 SUBSTITUTED HETEROCYCLES AS HSET INHIBITORS Merck Patent GmbH (DE) 2024-11-20 — — EP disclosed
CN-114976047-B Catalyst for electro-oxidation of methanol and preparation method thereof 南京大学 2024-08-23 — — CN disclosed
CN-118063470-A Condensed imidazole derivatives substituted with tertiary hydroxyl groups as PI 3K-gamma inhibitors 因赛特公司 2024-05-24 — — CN disclosed
CN-111542526-B Condensed imidazole derivatives substituted with tertiary hydroxyl groups as PI 3K-gamma inhibitors 因赛特公司 2024-01-09 — — CN disclosed
WO-2023177700-A2 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2023-09-21 — — WO disclosed
WO-2023131690-A1 SUBSTITUTED HETEROCYCLES AS HSET INHIBITORS MERCK PATENT GMBH (DE) 2023-07-13 — — WO disclosed
WO-2004018460-A1 AMINO METHYL IMIDAZOLES AS C5A RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2004-03-04 — — WO disclosed
CN-1119856-A Hiv reverse transcriptase inhibitors MERCK & CO INC (US) 1996-04-03 — — CN disclosed
US-4506074-A ANTIDEPRESSANTS, DECONGESTANTS MERCK & CO., INC. (US) 1985-03-19 — — US disclosed
US-4505918-A HYPOTENSIVE AND ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1985-03-19 — — US disclosed
US-4506074-A ANTIDEPRESSANTS, DECONGESTANTS MERCK & CO., INC. (US) 1985-03-19 — — US disclosed
US-4506074-A ANTIDEPRESSANTS, DECONGESTANTS MERCK & CO., INC. (US) 1985-03-19 — — US disclosed
US-4505918-A HYPOTENSIVE AND ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1985-03-19 — — US disclosed
US-4505918-A HYPOTENSIVE AND ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1985-03-19 — — US disclosed
US-4401629-A Selective imidazole ion exchange resins NATIONAL INSTITUTE FOR METALLURGY (ZA) 1983-08-30 — — US disclosed
Send feedback